We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
+4.82%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
AUM
$2.63B
AUM Growth
+$37.8M
Cap. Flow
-$20.9M
Cap. Flow %
-0.8%
Top 10 Hldgs %
30.56%
Holding
463
New
50
Increased
105
Reduced
223
Closed
33

Top Sells

Rank Stock Value
1
WDAY icon
Workday
WDAY
+$10.8M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10.1M
3
NVDA icon
NVIDIA
NVDA
+$9.51M
4
PLTR icon
Palantir
PLTR
+$7.58M
5
NVO
Novo Nordisk
NVO
+$7.03M

Sector Composition

Rank Sector Weight
1 Technology 26.71%
2 Healthcare 13.49%
3 Financials 11.12%
4 Industrials 9.23%
5 Consumer Discretionary 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDTT icon
251
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.53B
$1.79M 0.07%
74,557
+8,970
+14% +$217K
AVAV icon
252
AeroVironment
AVAV
$9.45B
$1.77M 0.07%
+7,336
New +$2.31M
TM icon
253
Toyota
TM
$225B
$1.77M 0.07%
8,264
+475
+6% +$96.4K
ASTH icon
254
Astrana Health
ASTH
$1.77B
$1.76M 0.07%
70,745
-1,932
-3% -$51.3K
CLX icon
255
Clorox
CLX
$12.7B
$1.7M 0.06%
16,859
-750
-4% -$81.4K
ATEC icon
256
Alphatec Holdings
ATEC
$1.44B
$1.7M 0.06%
80,695
-45,996
-36% -$851K
RARE icon
257
Ultragenyx Pharmaceutical
RARE
$2.55B
$1.69M 0.06%
73,484
+11,731
+19% +$386K
EVRG icon
258
Evergy
EVRG
$19.2B
$1.67M 0.06%
23,026
-1,150
-5% -$87.2K
CVS icon
259
CVS Health
CVS
$122B
$1.67M 0.06%
20,992
-974
-4% -$76.8K
PEP icon
260
PepsiCo
PEP
$190B
$1.62M 0.06%
11,259
-174
-2% -$25.6K
IVZ icon
261
Invesco
IVZ
$13.9B
$1.59M 0.06%
+60,651
New +$1.48M
SBUX icon
262
Starbucks
SBUX
$120B
$1.57M 0.06%
18,606
-90
-0.5% -$7.59K
XLK icon
263
State Street Technology Select Sector SPDR ETF
XLK
$124B
$1.56M 0.06%
10,833
+79
+0.7% +$11.4K
GMED icon
264
Globus Medical
GMED
$11.2B
$1.53M 0.06%
17,546
+2,698
+18% +$205K
GRBK icon
265
Green Brick Partners
GRBK
$3.14B
$1.52M 0.06%
24,181
-692
-3% -$45.6K
MO icon
266
Altria Group
MO
$114B
$1.51M 0.06%
26,213
-1,229
-4% -$74.2K
NKE icon
267
Nike
NKE
$61.9B
$1.49M 0.06%
23,423
+10,529
+82% +$686K
LAMR icon
268
Lamar Advertising Co
LAMR
$16.3B
$1.47M 0.06%
11,610
-543
-4% -$68K
BRK.B icon
269
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.45M 0.06%
2,886
+10
+0.3% +$4.97K
CME icon
270
CME Group
CME
$94.8B
$1.45M 0.06%
5,311
-254
-5% -$69K
NRG icon
271
NRG Energy
NRG
$24.8B
$1.44M 0.05%
9,013
-432
-5% -$71.5K
SLNO
272
DELISTED
Soleno Therapeutics
SLNO
$1.38M 0.05%
29,871
-25,859
-46% -$1.42M
IGSB icon
273
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$1.35M 0.05%
25,575
+2,511
+11% +$133K
USHY icon
274
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.7B
$1.33M 0.05%
35,491
+27,413
+339% +$1.03M
IGIB icon
275
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$1.32M 0.05%
24,416
+355
+1% +$19.2K

Similar funds

F/M Investments's Q4 2025 Portfolio in Review

As of Q4 2025, F/M Investments held 463 positions worth $2.63B, up 1.5% from $2.59B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

F/M Investments's Q4 2025 filing shows 50 new, 105 increased, 223 reduced and 33 closed positions. Its largest new stake was Xylem: 59,814 shares worth $8.15M. The largest sale was Workday, an estimated $10.8M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • F/M Investments's largest Q4 2025 buy was Xylem: 59,814 shares worth $8.15M.
  • F/M Investments added most to iShares Core US Aggregate Bond ETF in Q4 2025, an estimated $13.1M increase.
  • F/M Investments's biggest Q4 2025 reduction was Alphabet (Google) Class A, cutting an estimated $10.1M.
  • F/M Investments fully exited Workday in Q4 2025, selling an estimated $10.8M.
  • F/M Investments's ten largest holdings make up 31% of its $2.63B portfolio in Q4 2025.
  • F/M Investments opened 50 new positions and closed 33 in Q4 2025.
  • F/M Investments's portfolio value rose 1.5% quarter-over-quarter to $2.63B.

Based on F/M Investments's 13F filing for Q4 2025, filed 3 Feb 2026.